One of the biggest challenges in the modern molecular biology is to identify and functionally validate microRNAs (miRNAs) and their interactions with emerging classes of other noncoding RNAs (ncRNAs).
MiRNAs are a class small, single-stranded noncoding RNA molecules that control the expression of target genes mainly at the post-transcriptional level. Our lab contributed to uncover a prominent role for miRNAs as regulatory molecules that orchestrate gene expression in brain development, function and dysfunction. Our studies aim to uncover the mechanism and impact of ncRNA-dependent control of gene expression in brain science with the long-term goal to develop a next generation of therapeutics and diagnostics.
Our research activities is divided in two branches:
- Brain science: The overarching goal of our research is to understand the role played by miRNAs in mammalian brain development and (dys)function.
- Health: our task is to use small ncRNAs as a technology to develop novel RNA-based drugs for therapy and cell reprogramming. Our projects might have the potential to develop radically new approaches for brain therapy and repair.
Mol.biol. lab; cell cultures facilities (primary neural cells, immortalized lines); induced pluripotent human stem cells lab; histology lab. Access to IIT core facilities: Virus, Nikon center, Animal facility (SPF, individually ventilated cages; Surgery: electroporation, virus injection; behavior rooms; black cages in collaboration with Tecniplast (Italy)). Deep RNA/DNA seq. and RNAi screening facility.
- Microtechnology for Neuroelectronics (L. Berdondini) lab-on-chip read-outs for genetic models of human neural disorders
- CGS@SEMM, Milan (F. Nicassio), RNA profiling in Neurogenesis
- Polymers and Biomaterials (N.Tirelli) Nanomaterials for RNA delivery in brain
- Nanotechnology for Precision Medicine (P. Decuzzi) Polymeric nanostructures for RNA delivery in brain
National and International
- Prof. Dr. Gerd Kempermann, Director, CRTD and Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE), Dresden, Germany. Topic: Adult Neurogenesis
- Prof. Dr. Wieland B. Huttner, Director, Max-Planck Institute of Molecular Cell Biol and Genetics, Dresden, Germany. Topic: Embryonic Neurogenesis
- Tecniplast Spa, Buguggiate, VA, Italy.
- EU-REA, Marie Curie Actions (MCA) Call: FP7-PEOPLE-2010-RG. TITLE: NEUROGENESIS IN 22Q11.2 DELETION SYNDROME: ROLE OF microRNAs. ACRONYM: MIRNAS/22Q11DS. Project Budget, 100.000 Euros. Project duration 2011-2015.
- FP7-PEOPLE-2013-IEF. Acronym: “ASTROCLOCK”; Title “Astrocyte regulation of circadian behaviour”. Project Budget: 241.567 €; Project Duration: 2014 – 2016.
- AIRC - Associazione Italiana per la Ricerca sul Cancro. Title: Stimuli-Responsive Nanoparticles for eradicating different subsets of cancer cells within tumors. Collaborator; Project Budget 180.000 €; Project Duration 02/01/2014-01/01/2017.
- Fondazione CARIPLO, Call 2015 “Biomedical research on ageing-related diseases”. Title “Role of the astrocyte-mediated circadian clock in neurodegeneration and brain aging”. Co-Prinipal investigator. Project Budget 349,650 €. Project duration 2016-2020
- AIRC - Investigator Grant. Title: Differentiation therapy for GBM through synergic action of 11 miRNAs/drugs delivered via lipid/polymeric nanoparticles. Project Budget 599.610 €. Project Duration 2018-2022
- Process and device for the determination of alterations in neuronal connectivity and/or morphology; 2015-02-19 | patent PAT: US 20150051109 A1
- Composizione farmaceutica di miRNA e suoi usi terapeutici. Depositato all’ufficio brevetti Italiano Sept.,19th 2016. Rif IIT PT160330; n. 102016000093825